LakeShore Biopharma Co., Ltd. (LSB)
(Delayed Data from NSDQ)
$0.44 USD
0.00 (-0.02%)
Updated Aug 30, 2024 03:36 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 9/3/24 |
---|---|
Current Quarter | -0.09 |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.25 |
Next Year | NA |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 24.27M | 25.58M | 109.20M | 158.67M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 24.27M | 25.58M | 109.20M | 158.67M |
Low Estimate | 24.27M | 25.58M | 109.20M | 158.67M |
Year ago Sales | 24.40M | 13.64M | 85.67M | 109.20M |
Year over Year Growth Est. | -0.53% | 87.54% | 27.47% | 45.30% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.09 | -0.08 | -0.25 | NA |
# of Estimates | 1 | 1 | 1 | NA |
Most Recent Consensus | -0.09 | -0.08 | -0.25 | NA |
High Estimate | -0.09 | -0.08 | -0.25 | NA |
Low Estimate | -0.09 | -0.08 | -0.25 | NA |
Year ago EPS | -0.10 | -0.16 | -0.57 | -0.25 |
Year over Year Growth Est. | 10.00% | 50.00% | 56.14% | NA |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | NA |
Up Last 30 Days | 0 | 0 | 0 | NA |
Up Last 60 Days | 0 | 0 | 0 | NA |
Down Last 7 Days | 0 | 0 | 0 | NA |
Down Last 30 Days | 0 | 0 | 0 | NA |
Down Last 60 Days | 0 | 0 | 0 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Current | -0.09 | -0.08 | -0.25 | NA |
7 Days Ago | -0.09 | -0.08 | -0.25 | NA |
30 Days Ago | -0.09 | -0.08 | -0.25 | NA |
60 Days Ago | -0.09 | -0.08 | -0.25 | NA |
90 Days Ago | -0.09 | -0.08 | -0.25 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.09 | -0.08 | -0.25 | NA |
Zacks Consensus Estimate | -0.09 | -0.08 | -0.25 | NA |
Earnings ESP | 0.00% | 0.00% | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | -0.12 | -0.16 | -0.10 | NA |
Estimate | NA | NA | NA | NA | NA |
Difference | NA | NA | NA | NA | NA |
Surprise | NA | NA | NA | NA | NA |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more